you're right on the point that all we can do is make assumptions, because no one has a clue what's going on at this point as we approach 4 months of dead silence. there's an old investment adage "there's nothing the market hates more than uncertainty". and i think that's about right.

one would think that if anything positive has broken in our favor they would announce that immediately, given how starved shareholders are for info. but even absent anything good, taking a "no communication" approach is the worst approach - because not only does it leave us assuming the worst, but it torpedoes any respect or confidence in the board and in Antonio - as it's a cowardly approach. i would much prefer someone stepping up and delivering bad news, along with an explanation and a go-forward plan.

the "head in the sand" approach is just hard to fathom - even for an interim president and a sub-optimal board of directors. there's no excuse - they can give updates on plenty of things without running afoul of the FDA - that's just a weak excuse.